These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Safety evaluation of probiotic bifidobacteria by analysis of mucin degradation activity and translocation ability. Abe F; Muto M; Yaeshima T; Iwatsuki K; Aihara H; Ohashi Y; Fujisawa T Anaerobe; 2010 Apr; 16(2):131-6. PubMed ID: 19638311 [TBL] [Abstract][Full Text] [Related]
23. Analysis of host-inducing proteome changes in bifidobacterium longum NCC2705 grown in Vivo. Yuan J; Wang B; Sun Z; Bo X; Yuan X; He X; Zhao H; Du X; Wang F; Jiang Z; Zhang L; Jia L; Wang Y; Wei K; Wang J; Zhang X; Sun Y; Huang L; Zeng M J Proteome Res; 2008 Jan; 7(1):375-85. PubMed ID: 18027903 [TBL] [Abstract][Full Text] [Related]
24. Effect of administration of bifidobacteria on intestinal microbiota in low-birth-weight infants and transition of administered bifidobacteria: a comparison between one-species and three-species administration. Ishizeki S; Sugita M; Takata M; Yaeshima T Anaerobe; 2013 Oct; 23():38-44. PubMed ID: 23988359 [TBL] [Abstract][Full Text] [Related]
25. Signal peptide of Arabinosidase enhances secretion of interferon-alpha2b protein by Bifidobacteria longum. Deng Q; Zeng W; Yu Z Arch Microbiol; 2009 Sep; 191(9):681-6. PubMed ID: 19652954 [TBL] [Abstract][Full Text] [Related]
26. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens. Hütt P; Shchepetova J; Lõivukene K; Kullisaar T; Mikelsaar M J Appl Microbiol; 2006 Jun; 100(6):1324-32. PubMed ID: 16696680 [TBL] [Abstract][Full Text] [Related]
27. Exopolysaccharides produced by Bifidobacterium longum IPLA E44 and Bifidobacterium animalis subsp. lactis IPLA R1 modify the composition and metabolic activity of human faecal microbiota in pH-controlled batch cultures. Salazar N; Ruas-Madiedo P; Kolida S; Collins M; Rastall R; Gibson G; de Los Reyes-Gavilán CG Int J Food Microbiol; 2009 Nov; 135(3):260-7. PubMed ID: 19735956 [TBL] [Abstract][Full Text] [Related]
28. Selective growth-inhibitory effect of 8-hydroxyquinoline towards Clostridium difficile and Bifidobacterium longum subsp. longum in co-culture analysed by flow cytometry. Novakova J; Džunková M; Musilova S; Vlkova E; Kokoska L; Moya A; D'Auria G J Med Microbiol; 2014 Dec; 63(Pt 12):1663-1669. PubMed ID: 25298160 [TBL] [Abstract][Full Text] [Related]
29. Expression and secretion of Bifidobacterium adolescentis amylase by Bifidobacterium longum. Rhim SL; Park MS; Ji GE Biotechnol Lett; 2006 Feb; 28(3):163-8. PubMed ID: 16489493 [TBL] [Abstract][Full Text] [Related]
30. Cholesterol-lowering probiotics: in vitro selection and in vivo testing of bifidobacteria. Bordoni A; Amaretti A; Leonardi A; Boschetti E; Danesi F; Matteuzzi D; Roncaglia L; Raimondi S; Rossi M Appl Microbiol Biotechnol; 2013 Sep; 97(18):8273-81. PubMed ID: 23872958 [TBL] [Abstract][Full Text] [Related]
31. Genetically modified Bifidobacterium displaying Salmonella-antigen protects mice from lethal challenge of Salmonella Typhimurium in a murine typhoid fever model. Yamamoto S; Wada J; Katayama T; Jikimoto T; Nakamura M; Kinoshita S; Lee KM; Kawabata M; Shirakawa T Vaccine; 2010 Sep; 28(41):6684-91. PubMed ID: 20709009 [TBL] [Abstract][Full Text] [Related]
32. Dietary supplementation of Bifidobacterium longum strain AH1206 increases its cecal abundance and elevates intestinal interleukin-10 expression in the neonatal piglet. Herfel TM; Jacobi SK; Lin X; Jouni ZE; Chichlowski M; Stahl CH; Odle J Food Chem Toxicol; 2013 Oct; 60():116-22. PubMed ID: 23872134 [TBL] [Abstract][Full Text] [Related]
33. A Bifidobacterium-based synbiotic product to reduce the transmission of C. jejuni along the poultry food chain. Baffoni L; Gaggìa F; Di Gioia D; Santini C; Mogna L; Biavati B Int J Food Microbiol; 2012 Jul; 157(2):156-61. PubMed ID: 22608658 [TBL] [Abstract][Full Text] [Related]
34. A Bifidobacterium mixed-species microarray for high resolution discrimination between intestinal bifidobacteria. Boesten RJ; Schuren FH; de Vos WM J Microbiol Methods; 2009 Mar; 76(3):269-77. PubMed ID: 19141304 [TBL] [Abstract][Full Text] [Related]
35. In vitro fermentability of human milk oligosaccharides by several strains of bifidobacteria. Ward RE; Niñonuevo M; Mills DA; Lebrilla CB; German JB Mol Nutr Food Res; 2007 Nov; 51(11):1398-405. PubMed ID: 17966141 [TBL] [Abstract][Full Text] [Related]
36. Transformation of Bifidobacterium longum with pRM2, a constructed Escherichia coli-B. longum shuttle vector. Missich R; Sgorbati B; LeBlanc DJ Plasmid; 1994 Sep; 32(2):208-11. PubMed ID: 7846144 [TBL] [Abstract][Full Text] [Related]
37. Heterologous expression of cholesterol oxidase in Bifidobacterium longum under the control of 16S rRNA gene promoter of bifidobacteria. Park MS; Kwon B; Shim JJ; Huh CS; Ji GE Biotechnol Lett; 2008 Jan; 30(1):165-72. PubMed ID: 17849088 [TBL] [Abstract][Full Text] [Related]
38. Construction of Escherichia coli-Bifidobacterium longum shuttle vector transforming B. longum 105-A and 108-A. Matsumura H; Takeuchi A; Kano Y Biosci Biotechnol Biochem; 1997 Jul; 61(7):1211-2. PubMed ID: 9255988 [TBL] [Abstract][Full Text] [Related]
39. Immunogenicity of Bifidobacterium breve and change in antibody production in Peyer's patches after oral administration. Yasui H; Mike A; Ohwaki M J Dairy Sci; 1989 Jan; 72(1):30-5. PubMed ID: 2925954 [TBL] [Abstract][Full Text] [Related]
40. Construction of a reporter vector for the analysis of Bifidobacterium longum promoters. Klijn A; Moine D; Delley M; Mercenier A; Arigoni F; Pridmore RD Appl Environ Microbiol; 2006 Nov; 72(11):7401-5. PubMed ID: 16997985 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]